Internal Medicine · 2017 · 23 citations · 5 references
Life SciencesImmunologyOncologyAutoimmunityNeoplasiaNeuroimmunologyAutoantigensAutoimmune DiseasesAutoimmune Neurological DisordersTumor AntigensTumor ImmunopathologyTumor-associated AntigensAutoimmune Neurological DiseaseAutoimmune Paraneoplastic SyndromesEncephalitis PathogenesisImmune-mediated EncephalitisParaneoplastic Neurologic SyndromesParaneoplastic Neurological SyndromesParaneoplastic Syndromes In ThymomaThymic Tumors
We report a rare case of anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis presenting clinical relapse in association with recurrence of thymoma. Anti-AMPAR encephalitis is an autoimmune-mediated neurological disease, frequently accompanied by the presence of neoplasms, thus comprising the spectrum of paraneoplastic syndrome. A patient had been in remission for 34 months showed clinical relapse 3 months after the detection of recurrent thymoma. Clinical relapse of anti-AMPAR encephalitis after the recurrence of an initially detected neoplasm has not been previously reported. Our case therefore highlights the pathogenic relevance of specific tumor antigens as a trigger of anti-AMPAR antibody production and induction of the disease.
5
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
Meizan Lai, Ethan G. Hughes, Xiaoyu Peng et al. · Annals of Neurology · 2009 · 803 citations · Full text
Encephalitis and AMPA receptor antibodies
Romana Höftberger, Agnes van Sonderen, Frank Leypoldt et al. · Neurology · 2015 · 379 citations · Full text
THE EXPANDING CLINICAL PROFILE OF ANTI-AMPA RECEPTOR ENCEPHALITIS
Francesc Graus, Anna Boronat, Xavier Xifró et al. · Neurology · 2010 · 149 citations
REVERSIBLE PARANEOPLASTIC LIMBIC ENCEPHALITIS ASSOCIATED WITH ANTIBODIES TO THE AMPA RECEPTOR
Luís Bataller, Robert D. Galiano, M García-Escrig et al. · Neurology · 2010 · 127 citations · Full text
Life Sciences, Neurology, Oncology +17